Doctor profile · Federal record

Dr. Sreelatha Chalasani, MD

Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Internal Medicine Physician · Rock Hill, SC

  • NPI 1063618080
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 25 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
744 Arden Ln Ste 225
Rock Hill, SC 297323288
(803) 329-1660
fax (803) 329-4118

Credentials & registration

NPPES · NUCC
NPI registered
June 2007 — 19 yrs on file
Profile last updated
March 30, 2021
Year of graduation
2001 — 25 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State licenses (2)
South Carolina #MD52058 · Wisconsin #48675

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1063618080. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
98,905
Distinct HCPCS
10
Medicare allowed
$1,648,551
HCPCS Description Services Patients Avg allowed
J1602 Injection, golimumab, 1 mg, for intravenous use 39,856 50 $13
J3111 Injection, romosozumab-aqqg, 1 mg 30,870 30 $10
J0897 Injection, denosumab, 1 mg 24,660 259 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 909 418 $121
86235 Measurement of antibody for assessment of autoimmune disorder, any method 630 90 $17
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 490 262 $67
96413 Administration of chemotherapy into vein, 1 hour or less 371 82 $121
82306 Vitamin d-3 level 222 214 $29
83516 Analysis of substance using immunoassay technique, multiple step method 178 89 $11
86039 Measurement of antibody for assessment of autoimmune disorder, titer 90 90 $11

In context: peer comparison

Among 2 peers in this city , average services per provider: 4,423. This provider delivers 22× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,703
Transactions
82
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen Inc. 23 $227.13
Janssen Biotech, Inc. 7 $184.18
PFIZER INC. 8 $170.36
Novartis Pharmaceuticals Corporation 8 $166.81
GlaxoSmithKline, LLC. 5 $149.27
ABBVIE INC. 6 $139.74
AstraZeneca Pharmaceuticals LP 4 $115.30
UCB, Inc. 3 $86.86
Alexion Pharmaceuticals, Inc. 4 $83.53
Lilly USA, LLC 4 $78.70
Sandoz Inc. 3 $66.21
SCILEX PHARMACEUTICALS INC. 3 $64.12
Boehringer Ingelheim Pharmaceuticals, Inc. 2 $62.95
Fresenius Kabi USA, LLC 1 $26.11
GENZYME CORPORATION 1 $23.45

By nature of payment

Food and Beverage
$1,703

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,536
Patients
791
Total drug cost
$240,129
Drug Type Claims Patients Total cost
Prednisone Generic 600 193 $4,955
Methotrexate (Methotrexate Sodium) Brand 553 149 $16,632
Hydroxychloroquine Sulfate Generic 325 101 $24,158
Sulfasalazine Generic 186 53 $3,649
Azathioprine Generic 146 43 $7,628
Alendronate Sodium Generic 140 54 $1,328
Leflunomide Generic 133 34 $8,233
Folic Acid Generic 93 23 $398
Meloxicam Generic 89 51 $475
Allopurinol Generic 83 26 $1,294

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Sreelatha Chalasani's medical specialty?
Dr. Sreelatha Chalasani practices Rheumatology Physician in Rock Hill, SC.
Where does Dr. Sreelatha Chalasani practice?
Dr. Sreelatha Chalasani practices at 744 Arden Ln Ste 225, Rock Hill, SC 297323288. Office phone: 8033291660.
What is Dr. Sreelatha Chalasani's NPI?
Dr. Sreelatha Chalasani's National Provider Identifier (NPI) is 1063618080, issued by NPPES.
Does Dr. Sreelatha Chalasani accept Medicare assignment?
Yes. Dr. Sreelatha Chalasani accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sreelatha Chalasani commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.